Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast Cancer

NCT00317720 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Neoplasm Metastasis

Interventions

DRUG: Trastuzumab
DRUG: RAD001

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]